Linking transcriptomic and proteomic data on the level of protein interaction networks

Integration and joint analysis of omics profiles derived on the genome, transcriptome, proteome and metabolome levels is a natural next step in realizing a Systems Biology view of cellular processes. However, merging, e.g. mRNA concentration and protein abundance profiles, is not straightforward, as a direct overlap of differentially regulated/abundant features, resulting from transcriptomics and proteomics, is for various reasons limited. We present the procedures for integrating omics profiles at the level of protein interaction networks, exemplified by using transcriptomic and proteomic data sets characterizing chronic kidney disease. On the level of direct feature overlap, only a limited number of genes and proteins were found to be significantly affected following a separate transcript and protein profile analysis, including a collagen subtype and uromodulin, both being described in the context of renal failure. On the level of protein pathway and process categories, this minor overlap increases substantially, identifying cell structure, cell adhesion, as well as immunity and defense mechanisms as jointly populated with features individually identified as relevant in transcriptomics and proteomics experiments. Mapping diverse data sources characterizing a given phenotype under the analysis on directed and also undirected protein interaction networks serves in joint functional interpretation of omics data sets.

[1]  Igor Jurisica,et al.  Online Predicted Human Interaction Database , 2005, Bioinform..

[2]  S. Hanash Disease proteomics : Proteomics , 2003 .

[3]  A Lukas,et al.  Protein biomarkers associated with acute renal failure and chronic kidney disease , 2006, European journal of clinical investigation.

[4]  Alberto Riva,et al.  The MAPPER database: a multi-genome catalog of putative transcription factor binding sites , 2004, Nucleic Acids Res..

[5]  M. Rudnicki,et al.  Gene expression profiles of human proximal tubular epithelial cells in proteinuric nephropathies. , 2007, Kidney international.

[6]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[7]  M. Mann,et al.  Is Proteomics the New Genomics? , 2007, Cell.

[8]  Arno Lukas,et al.  Linking the ovarian cancer transcriptome and immunome , 2008, BMC Systems Biology.

[9]  Alberto Riva,et al.  The MAPPER2 Database: a multi-genome catalog of putative transcription factor binding sites , 2004, Nucleic Acids Res..

[10]  K. Kadota,et al.  Correlation Analysis of mRNA and Protein Abundances in Human Tissues , 2003 .

[11]  S. Gygi,et al.  Correlation between Protein and mRNA Abundance in Yeast , 1999, Molecular and Cellular Biology.

[12]  Susumu Goto,et al.  KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..

[13]  Dennis B. Troup,et al.  NCBI GEO: archive for high-throughput functional genomic data , 2008, Nucleic Acids Res..

[14]  H. Baelde,et al.  Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  M. Rudnicki,et al.  Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease , 2009, Laboratory Investigation.

[16]  O. Samuelsson,et al.  The compositional abnormalities of lipoproteins in diabetic renal failure. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  Amos Bairoch,et al.  Swiss-Prot: Juggling between evolution and stability , 2004, Briefings Bioinform..

[18]  E. Lundberg,et al.  A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies* , 2008, Molecular & Cellular Proteomics.

[19]  Felix Eichinger,et al.  Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy , 2006, Diabetes.

[20]  Tao Liu,et al.  Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models , 2008, Bioinform..

[21]  A. Dominiczak,et al.  CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics , 2008, Proteomics. Clinical applications.

[22]  B. Mayer,et al.  Transforming omics data into context: Bioinformatics on genomics and proteomics raw data , 2006, Electrophoresis.

[23]  Mark Gerstein,et al.  Analysis of mRNA expression and protein abundance data: an approach for the comparison of the enrichment of features in the cellular population of proteins and transcripts , 2002, Bioinform..

[24]  Y. Urade,et al.  Urinary PGDS levels are associated with vascular injury in type 2 diabetes patients. , 2007, Diabetes research and clinical practice.

[25]  Jae K. Lee,et al.  Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study , 2007, Molecular Cancer Therapeutics.

[26]  E. Marcotte,et al.  Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation , 2007, Nature Biotechnology.

[27]  P. Maxwell,et al.  Organ-Specific Collagen Expression: Implications for Renal Disease , 2005, Nephron Experimental Nephrology.

[28]  M. Boguski,et al.  dbEST — database for “expressed sequence tags” , 1993, Nature Genetics.

[29]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[30]  M. Gerstein,et al.  Comparing protein abundance and mRNA expression levels on a genomic scale , 2003, Genome Biology.

[31]  S. Peltonen,et al.  Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney. , 1997, The American journal of pathology.

[32]  Nan Guo,et al.  PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways , 2006, Nucleic Acids Res..

[33]  N. Powe,et al.  International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. , 2006, Journal of the American Society of Nephrology : JASN.

[34]  Atul Butte,et al.  The use and analysis of microarray data , 2002, Nature Reviews Drug Discovery.

[35]  Harald Mischak,et al.  Urinary proteomics in diabetes and CKD. , 2008, Journal of the American Society of Nephrology : JASN.

[36]  Arno Lukas,et al.  A dependency graph approach for the analysis of differential gene expression profiles. , 2009, Molecular bioSystems.